相关实验视频

Updated: Jan 11, 2026

Author Spotlight: Decellularization-Based Quantification of Skeletal Muscle Fatty Infiltration
10:37

Author Spotlight: Decellularization-Based Quantification of Skeletal Muscle Fatty Infiltration

Published on: June 9, 2023

3.9K

慢性肝病中四头肌肌间脂肪组织增加与与健康年龄相匹配的对照人群相比,与改变的肌肉转录组有关

J I Quinlan1,2, T Nicholson3,4, C Bell5

  • 1School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, UK. j.quinlan@bham.ac.uk.

GeroScience
|November 14, 2025
PubMed
概括

肌肉脂肪透 (骨髓炎) 在慢性肝病 (CLD) 患者中较高,无论位置如何. 这种增加的肌肉间脂肪组织 (IMAT) 与肌肉功能的减少和基因表达的改变相关,可能会加剧肌肉损失.

关键词:
慢性肝病是一种慢性肝病.肌肉间脂肪组织组织.肌肉转录基因组是肌肉转录基因组的一个组成部分.骨髓骨质炎 (Myosteatosis) 是一种骨髓骨质的疾病.萨尔科佩尼亚是什么意思 萨尔科佩尼亚骨架肌肉是一个骨肌肉.

更多相关视频

A Guide to Examining Intramuscular Fat Formation and its Cellular Origin in Skeletal Muscle09:19

A Guide to Examining Intramuscular Fat Formation and its Cellular Origin in Skeletal Muscle

Published on: May 26, 2022

4.7K
Fiber Type and Subcellular-Specific Analysis of Lipid Droplet Content in Skeletal Muscle11:50

Fiber Type and Subcellular-Specific Analysis of Lipid Droplet Content in Skeletal Muscle

Published on: June 8, 2022

4.9K

相关概念视频

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
163
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.8K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
230